The use of these services in oncology is likely here to stay.
February 2022
The drug's novel molecular structure may result in fewer toxic adverse effects.
A variety of drugs from several medication classes are under investigation.
An emerging focus is aligning targeted, safe, and effective therapies with patient goals.
The uncommon disease shares features of both lymphoma and myeloma.
Effective specialty pharmacies learn to meet the changing needs of patients and stakeholders.
The industry has been ushered into a new age of medicine.
Mike Hennessy was the beloved chairman and CEO of MJH Life Sciences.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Improving RSV Vaccine Coverage Could Prevent Thousands of Severe Cases in Older Adults
3
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
4
PCV20 Demonstrates Real-World Effectiveness Against Pneumonia in Older Adults
5
